SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...

Problems with clinical reasoning and imaging interpretation were factors in nearly half of lower GI perforation cases with ...

Flu season is in full swing, making it more important than ever to take steps to protect yourself and your loved ones.